Catalyst Wire Dossier Catalyst Wire Dossier

Hiltonol

Poly-ICLC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Hiltonol, covering 2014-03-28 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706 [Phase 1]

See pricing